Table 1 Demographic and clinical characteristics of patients diagnosed with bladder cancer in terms of mean survival rate using Kaplan–Meier method
Characteristic | Category | Frequency (%) | Mean survival per month (95% CI) | p* |
|---|---|---|---|---|
Sex | Female | 57 (17.7) | 57.4 (50–64.8) | 0.04 |
male | 264 (82.2) | 48.9 (45.2–52.6) | ||
Age at diagnosis | ≤ 50 y | 43 (13.4) | 60.3 (53.1–67.5) | < 0.001 |
51–64 y | 105 (32.7) | 55.8 (50.5–61) | ||
≥ 65 y | 173 (53.9) | 44.3 (39.7–48.9) | ||
Marital status | Single (unmarried, divorced, widow/widower) | 39 (12.1) | 32.7 (23.8–41.5) | < 0.001 |
Married | 282 (87.8) | 52.9 (49.5–56.4) | ||
Residence | Rural | 74 (23.5) | 41.7 (35.3–47.9) | < 0.001 |
Urban | 247 (76.9) | 53.9 (50.2–57.7) | ||
Occupation | Unemployed/Retired | 67 (20.8) | 58.9 (52.5–65.3) | 0.008 |
Housewife | 47 (14.6) | 56.2 (47.9–64.5) | ||
Worker | 53 (16.5) | 48.8 (39.6–57.9) | ||
Self-employed | 66 (20.5) | 48.1 (40.5–55.7) | ||
Office job | 27 (8.4) | 47.7 (39.3–55.9) | ||
Agriculturist | 61 (19.0) | 41.6 (34.9–48.2) | ||
Education | Illiterate | 158 (49.2) | 45.3 (40.5–50.1) | 0.001 |
Literate | 163 (50.7) | 55.8 (51.4–60.2) | ||
Socioeconomic status | Poor | 106 (33.1) | 42.4 (36.9–47.8) | < 0.001 |
Moderate | 107 (33.4) | 52.3 (46.5–57.9) | ||
Rich | 107 (33.4) | 58.5 (53.2–63.8) | ||
Smoking | No | 172 (53.5) | 51.7 (46.6–56.7) | 0.5 |
Yes | 149 (46.4) | 49.4 (45–53.7) | ||
Family history of BC | No | 301 (93.7) | 50.0 (46.5–53.4) | 0.5 |
Yes | 20 (6.2) | 54.6 (43.3–65.9) | ||
Comorbidity | No | 205 (63.8) | 50.8 (46.7–54.8) | 0.5 |
Yes | 116 (34.1) | 49.3 (43.6–54.9) | ||
TNM stage | I | 210 (65.4) | 58.5 (55–62) | < 0.001 |
II | 74 (23) | 44.5 (37.2–51.7) | ||
III | 29 (9) | 21.7 (12.9–30.4) | ||
IV | 8 (2.5) | 21.3 (8.9–33.6) | ||
Grade | Poorly differentiated | 217 (67.6) | 59.7 (56.3–62.9) | < 0.001 |
Well differentiated | 104 (32.4) | 31.6 (25.8–37.3) | ||
Treatment | Radiation therapy | 13 (4) | 48.2 (34.5–61.7) | 0.05 |
Surgery | 207 (64.5) | 53.6 (49.6–57.5) | ||
Chemotherapy | 10 (3.1) | 31.9 (20.3–43.5) | ||
Combinational treatment (Surgery, Radiotherapy, Chemotherapy or Immunotherapy) | 85 (26.4) | 44.5 (38–50.8) | ||
Histology | Adenocarcinoma | 10 (3.1) | 34.7 (24.8–44.5) | 0.03 |
Squamous cell carcinoma | 7 (2.1) | 24.9 (3.7–46) | ||
Urothelial carcinoma | 304 (94.7) | 51.3 (47.9–54.7) | ||
Method of diagnosis | Urinalysis and ultrasound | 55 (17.1) | 52.9 (46.5–59.3) | 0.5 |
Cystoscopy and biopsy | 55 (17.1) | 45.4 (37.7–53) | ||
Biopsy and ultrasound | 35 (10.9) | 50.0 (40.6–59.3) | ||
Combinational method of diagnosis | 176 (54.8) | 50.8 (46.1–55.6) | ||
Poison and pesticides exposure | Yes | 64 (19.9) | 49.9 (43.5–56.4) | 0.9 |
No | 257 (80) | 50.5 (46.7–54.3) |